CBS-0550
id:
cbs-0550-241-3543976
title:
CBS-0550
text:
CBS-0550 is a drug developed by Taisho Pharmaceutical, which acts as a potent and selective cannabinoid CB2 receptor agonist, with 1400x selectivity for CB2 over the related CB1 receptor. Unlike most cannabinoid agonists, CBS-0550 has good solubility in water, and in animal studies it was found to produce analgesic and anti-hyperalgesic effects. A number of related compounds have been developed with similar properties.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/CBS-0550
date created:
date modified:
2022-04-16T14:18:22Z
main entity:
{"identifier":"Q5009205","url":"https://www.wikidata.org/entity/Q5009205"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/7d/CBS-0550.svg","width":109,"height":118}
fields total:
13
integrity:
15